Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination (Q84890831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Shigenobu Emoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hironori Ishigami

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hironori Yamaguchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Shoichi Kaisaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Joji Kitayama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

3 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

154-161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21892754%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10120-011-0091-8

12 February 2020

exact match

0 references

cites work

Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma

1 reference

12 December 2020

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

1 reference

12 December 2020

The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer

1 reference

12 December 2020

Serum and tissue measurements of CA72-4 in ovarian cancer patients

1 reference

12 December 2020

Follow-up of gastric cancer: a review

1 reference

12 December 2020

Correlates of the preoperative level of CA125 at presentation of ovarian cancer

1 reference

12 December 2020

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

1 reference

12 December 2020

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

1 reference

12 December 2020

An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer.

1 reference

12 December 2020

Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.

1 reference

12 December 2020

Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma

1 reference

12 December 2020

A spectrum of monoclonal antibodies reactive with human mammary tumor cells

1 reference

12 December 2020

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

1 reference

12 December 2020

Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis

1 reference

12 December 2020

The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study

1 reference

12 December 2020

Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

CA125 in ovarian cancer

1 reference

12 December 2020

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

1 reference

12 December 2020

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer

1 reference

12 December 2020

CA72-4: a new tumour marker for gastric cancer

1 reference

12 December 2020

Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer

1 reference

12 December 2020

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer

1 reference

12 December 2020

[The importance of CA125 immunohistochemical staining in patients with ovarian cancer]

1 reference

12 December 2020

Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma

1 reference

12 December 2020

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

1 reference

12 December 2020